Published in Cancer Lett on January 15, 1993
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) N Engl J Med (2000) 8.02
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med (1994) 5.03
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst (1998) 4.43
Efficient transfer of highly resolved small DNA fragments from polyacrylamide gels to DBM paper. Gene (1980) 3.30
Dose: a critical factor in cancer chemotherapy. Am J Med (1980) 2.82
Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med (1975) 2.71
A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B. JAMA (1993) 2.60
The nature and control of infections in patients with acute leukemia. Cancer Res (1965) 2.55
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med (1988) 2.23
Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med (1974) 2.02
[Recommendations for diagnosis and therapy of chronic heart failure 2001--the short version]. Vnitr Lek (2004) 1.95
Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science (1990) 1.93
A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res (1978) 1.88
Clinical trials with adriamycin. Cancer (1971) 1.86
Spilled gallstones after laparoscopic cholecystectomy. A relevant problem? A retrospective analysis of 10,174 laparoscopic cholecystectomies. Surg Endosc (1998) 1.77
A lesson from Canada: Ontario's health insurance. N Engl J Med (1978) 1.76
Carcinoembryonic antigen: clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer (1974) 1.74
Urothelial malignant disease and Chinese herbal nephropathy. Lancet (2001) 1.73
Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. J Natl Cancer Inst (1988) 1.73
Controlled multicenter trial of laparoscopic transabdominal preperitoneal hernioplasty vs Shouldice herniorrhaphy. Early results. Surg Endosc (1996) 1.71
The Polycomb-group gene, extra sex combs, encodes a nuclear member of the WD-40 repeat family. EMBO J (1995) 1.69
Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet (1973) 1.66
Complications of laparoscopic cholecystectomy in Switzerland. A prospective 3-year study of 10,174 patients. Swiss Association of Laparoscopic and Thoracoscopic Surgery. Surg Endosc (1998) 1.65
Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"? Am J Kidney Dis (2001) 1.61
Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT). Cardiovasc Res (2001) 1.53
Studies of patients in a laminar air flow unit. Cancer (1969) 1.49
Combination cancer therapy: Presidential address. Cancer Res (1972) 1.47
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol (1983) 1.45
Intensive combination chemotherapy and X-irradiation in Hodgkin's disease. Cancer Res (1967) 1.44
Selection bias in clinical trials. J Clin Oncol (1985) 1.42
Complex regulation of early paired expression: initial activation by gap genes and pattern modulation by pair-rule genes. Development (1993) 1.39
Preoperative Nyhus classification of inguinal hernias and type-related individual hernia repair. A case for diagnostic laparoscopy. Surg Laparosc Endosc (1997) 1.39
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res (1983) 1.39
[Early results of the initial 100 laparoscopic hernia operations under peridural anesthesia]. Schweiz Med Wochenschr (1995) 1.39
Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts. Cancer Res (1976) 1.38
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol (1988) 1.37
Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma. Cancer (1971) 1.37
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med (1980) 1.37
Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine. Clin Pharmacol Ther (1972) 1.35
Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). Cancer Res (1969) 1.33
Role of murine tumor models in cancer treatment research. Cancer Res (1986) 1.30
Studiesof a patient isolator unit and prophylactic antibiotics in cancer chemotherapy. General techniques and preliminary results. Cancer (1968) 1.28
Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res (1996) 1.28
The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts. Biochem Pharmacol (2001) 1.27
Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission. Ann Intern Med (1973) 1.27
The National Cancer Chemotherapy Program. Science (1982) 1.26
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25
The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood (1965) 1.23
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res (1987) 1.23
The role of cholesteryl 14-methylhexadecanoate in peptide elongation reactions. Biochem J (1971) 1.23
double-time is identical to discs overgrown, which is required for cell survival, proliferation and growth arrest in Drosophila imaginal discs. Development (1999) 1.23
Progress and perspectives in the chemotherapy of acute leukemia. Adv Chemother (1965) 1.22
The effect of skin homograft rejection on recipient and donor mixed leukocyte cultures. J Exp Med (1965) 1.22
Cell proliferation in human melanoma. J Clin Invest (1970) 1.21
shaven and sparkling are mutations in separate enhancers of the Drosophila Pax2 homolog. Development (1998) 1.18
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide. Cancer (1972) 1.18
Osteosarcoma: fifteen years later. N Engl J Med (1985) 1.17
Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Cancer Res (1986) 1.15
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response. J Clin Oncol (1992) 1.15
L-dopa: selective toxicity for melanoma cells in vitro. Science (1977) 1.15
Adverse effects of intrathecal methotrexate in children with acute leukemia in remission. Blood (1975) 1.14
New approaches to cancer chemotherapy with methotrexate. N Engl J Med (1975) 1.12
Influence of cholesteryl 14-methylhexadecanoate on some ribosomal functions required for peptide elongation. Biochem J (1974) 1.12
Chemotherapy of malignant lymphoma with adriamycin. Cancer Res (1973) 1.11
Pharmacokinetics of actinoymcin D in patients with malignant melanoma. Clin Pharmacol Ther (1975) 1.10
High-dose ifosfamide with mesna uroprotection: a phase I study. J Clin Oncol (1990) 1.09
Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemia. Lancet (1980) 1.09
Passover: a gene required for synaptic connectivity in the giant fiber system of Drosophila. Cell (1993) 1.07
Effect of cholesteryl 14-methylhexadecanoate on the activity of some amino acid-transfer ribonucleic acid ligases from mammalian tissues. Biochem J (1969) 1.06
Prognotic significance of pretreatment proliferative activity in adult acute leukemia. Cancer (1977) 1.06
32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis (1997) 1.05
Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro. Cancer Res (1977) 1.05
Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia. Am J Med Sci (1971) 1.05
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support. J Clin Oncol (1989) 1.04
Phase II study of topotecan in metastatic non-small-cell lung cancer. J Clin Oncol (1994) 1.03
Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1. Proc Natl Acad Sci U S A (1998) 1.03
Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues. Cancer Res (1990) 1.02
Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA. Carcinogenesis (1990) 1.02
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity. Am J Med (1980) 1.02
Alkylating agent resistance: in vitro studies with human cell lines. Proc Natl Acad Sci U S A (1985) 1.01
Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small cell lung cancer: long-term follow-up in 41 patients. J Surg Oncol (1989) 1.01
Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture. Proc Natl Acad Sci U S A (1984) 1.01
Pharmacologic studies of the antitumor agent 5-(dimethyltriazeno)imidazole-4-carboxamide. Cancer Res (1968) 1.01
Post-surgical follow-up (by ELISA and immunoblotting) of cured versus non-cured cystic echinococcosis in young patients. Parasitology (2007) 1.01
Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP). Blood (1977) 1.00
The Philadelphia chromosome and chronic myelogenous leukemia. J Natl Cancer Inst (1966) 1.00
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma. Cancer (1980) 1.00
N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin. Cancer Res (1975) 1.00
Curative cancer chemotherapy. Cancer Res (1985) 1.00
High-dose methotrexate in osteogenic sarcoma: a 5-year experience. Cancer Treat Rep (1978) 0.98
Acute lymphoblastic leukemia: treatment. Cancer (1978) 0.98
Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts. J Cell Biol (1975) 0.98
Clinical cancer research: an embattled species. Cancer (1982) 0.98
Characterization of lidocaine-specific T cells. J Immunol (1997) 0.98
Improved serodiagnosis of alveolar echinococcosis of humans using an in vitro-produced Echinococcus multilocularis antigen. Parasitology (2007) 0.98